Target intelligence / Profile preview

Tumor cell apoptosis signaling pathways

Molecular classification
Other (umbrella term for signaling pathways), Includes individual members from:, Receptor (e.g., death receptors such as Fas, TNFR1, DR4/5), Enzyme (e.g., caspases), Transcription factor (e.g., p53), Regulatory protein families (e.g., Bcl-2 family)
01

Overview

“Tumor cell apoptosis signaling pathways” encompasses the diverse molecular and cellular processes that regulate programmed cell death in cancer cells. The two main canonical pathways are: Extrinsic pathway: Initiated by the binding of death ligands (e.g., Fas ligand, TRAIL, TNFα) to cell-surface death receptors (Fas, TNFR1, DR4/5), leading to formation of a death-inducing signaling complex (DISC) and activation of initiator caspases (caspase-8, -10). Intrinsic pathway: Mediated by mitochondrial signals and regulated by the Bcl-2 family of proteins. Cellular stress (DNA damage, oxidative stress) releases cytochrome c from mitochondria, which forms the apoptosome, activating caspase-9 and executing apoptosis. Major regulators include p53 (a tumor suppressor transcription factor), which controls both apoptotic pathways, influencing cell fate in response to stress or damage. Therapeutic targeting of apoptotic signaling pathways in cancer aims to restore or enhance apoptosis in malignant cells resistant to programmed cell death. Summary: The entry “Tumor cell apoptosis signaling pathways” is not a specific, canonical molecular target but rather a functional biological concept involving numerous molecules (receptors, enzymes, transcription factors). For structured data, consider extracting and focusing on individual canonical targets within these pathways (e.g., “Tumor necrosis factor receptor 1”, “Fas”, “Death receptor 4/5”, “Bcl-2”, “Caspase-8”, “p53”).

Other names
Apoptotic signaling pathways in tumor cellsCancer cell apoptosis pathwaysCell death signaling cascades in cancer
02

Mechanism of action

Induction of apoptosis via extrinsic (death receptor) pathway; Modulation of intrinsic (mitochondrial) pathway, e.g., targeting Bcl-2 family proteins; Activating p53-dependent cell death response; Direct or indirect caspase activation

03

Biological functions

ApoptosisSignal transductionCell deathTumor suppressionRegulation of cell cycle
04

Disease associations

Cancer (major, including resistance and sensitivity to chemotherapy)Neurodegenerative diseaseAutoimmune disease
05

Safety considerations

Off-target induction of apoptosis in non-tumor cells can cause toxicityImmunosuppression, autoimmunity (with generalized apoptotic pathway activation)Tumor resistance via mutations (e.g., mutated p53 or overexpression of anti-apoptotic proteins like Bcl-2)Cytokine release syndrome (with death receptor ligands)
06

Interacting drugs

Small-molecule inhibitors/activators of Bcl-2 (e.g., venetoclax)

4 more in the full profile.

07

Biomarkers

Expression of death receptors: Fas, TNFR1, DR4, DR5Mutational status of p53Balance of Bcl-2 family protein expression (e.g., Bcl-2/Bax ratio)Caspase activityLevels of TRAIL or Fas ligand

Beyond the preview

Go deeper on Tumor cell apoptosis signaling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor cell apoptosis signaling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call